Amarin AMRN Stock
Amarin Price Chart
Amarin AMRN Financial and Trading Overview
| Amarin stock price | 0.96 USD |
| Previous Close | 1.23 USD |
| Open | 1.23 USD |
| Bid | 0 USD x 36100 |
| Ask | 0 USD x 40700 |
| Day's Range | 1.18 - 1.24 USD |
| 52 Week Range | 1.04 - 2.23 USD |
| Volume | 2.32M USD |
| Avg. Volume | 2.32M USD |
| Market Cap | 485.26M USD |
| Beta (5Y Monthly) | 1.786066 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.15 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.13 USD |
AMRN Valuation Measures
| Enterprise Value | 195.29M USD |
| Trailing P/E | N/A |
| Forward P/E | -8.5 |
| PEG Ratio (5 yr expected) | -0.19 |
| Price/Sales (ttm) | 1.3459281 |
| Price/Book (mrq) | 0.8286908 |
| Enterprise Value/Revenue | 0.542 |
| Enterprise Value/EBITDA | -4.072 |
Trading Information
Amarin Stock Price History
| Beta (5Y Monthly) | 1.786066 |
| 52-Week Change | -34.97% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.23 USD |
| 52 Week Low | 1.04 USD |
| 50-Day Moving Average | 1.3 USD |
| 200-Day Moving Average | 1.4 USD |
AMRN Share Statistics
| Avg. Volume (3 month) | 2.32M USD |
| Avg. Daily Volume (10-Days) | 1.39M USD |
| Shares Outstanding | 407.78M |
| Float | 385.27M |
| Short Ratio | 7.84 |
| % Held by Insiders | 0.48% |
| % Held by Institutions | 34.57% |
| Shares Short | 20.5M |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 5.03% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -25.15% |
| Operating Margin (ttm) | -14.15% |
| Gross Margin | 68.88% |
| EBITDA Margin | -13.30% |
Management Effectiveness
| Return on Assets (ttm) | -3.47% |
| Return on Equity (ttm) | -14.79% |
Income Statement
| Revenue (ttm) | 360.54M USD |
| Revenue Per Share (ttm) | 0.89 USD |
| Quarterly Revenue Growth (yoy) | -9.099% |
| Gross Profit (ttm) | 260.56M USD |
| EBITDA | -47964000 USD |
| Net Income Avi to Common (ttm) | -90700000 USD |
| Diluted EPS (ttm) | -0.22 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 304.37M USD |
| Total Cash Per Share (mrq) | 0.79 USD |
| Total Debt (mrq) | 11.65M USD |
| Total Debt/Equity (mrq) | 1.99 USD |
| Current Ratio (mrq) | 2.8 |
| Book Value Per Share (mrq) | 1.436 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -88253000 USD |
| Levered Free Cash Flow (ttm) | -30330500 USD |
Profile of Amarin
| Country | United States |
| State | N/A |
| City | Dublin |
| Address | Iconic Offices, The Greenway |
| ZIP | 112-114 |
| Phone | 353 0 166 99020 |
| Website | https://www.amarincorp.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 365 |
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Q&A For Amarin Stock
What is a current AMRN stock price?
Amarin AMRN stock price today per share is 0.96 USD.
How to purchase Amarin stock?
You can buy AMRN shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Amarin?
The stock symbol or ticker of Amarin is AMRN.
Which industry does the Amarin company belong to?
The Amarin industry is Drug Manufacturers-General.
How many shares does Amarin have in circulation?
The max supply of Amarin shares is 401.36M.
What is Amarin Price to Earnings Ratio (PE Ratio)?
Amarin PE Ratio is now.
What was Amarin earnings per share over the trailing 12 months (TTM)?
Amarin EPS is -0.15 USD over the trailing 12 months.
Which sector does the Amarin company belong to?
The Amarin sector is Healthcare.
Amarin AMRN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4501.69 USD — |
-2.14
|
— — | 4479.13 USD — | 4578.05 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}